Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-27 @ 6:28 PM
Study NCT ID:
NCT03949192
Status:
UNKNOWN
Last Update Posted:
2020-05-05
First Post:
2019-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Kangliuwan for Recurrent Grade IV Glioma
Sponsor:
Xuanwu Hospital, Beijing
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-11
First Submit QC Date:
None
Study First Post Date:
2019-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-30
Last Update Post Date:
2020-05-05
Last Update Post Date Type:
ACTUAL